3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
14
Prostatic Neoplasms
12
Burkitt Lymphoma
11
Lymphoma, Follicular
9
Lymphoma
6
Prostatic Neoplasms, Castration-Resistant
5
Neoplasms
4
Lymphoma, Non-Hodgkin
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Lymphoproliferative Disorders
2
Lymphoma, B-Cell
2
Recurrence
1
Prostate Cancer Metastatic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multi-centric Castleman's Disease
1
Metastatic Castration-sensitive Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castration-resistant Prostate Cancer
1
Melanoma
1
Macular dystrophy, corneal type 1
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Hairy Cell
1
Leukemia, B-Cell
1
Interventions
empagliflozin
1
Environmental Biomarkers
1
Echocardiography
1
Carvedilol
1
Blood Pressure Determination
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Prednisone
×
30 days
×
Clear all
No trials found.